Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Scientific Reports
|
November 20, 2015
Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury
Marc A DePaul, Marc Palmer, Bradley T Lang, et al.
Journal of Neuroinflammation
|
December 25, 2015
Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain
Reint K Jellema, Daan R M G Ophelders, Alex Zwanenburg, et al.
Behavioural Brain Research
|
January 15, 2019
Systemic multipotent adult progenitor cells improve long-term neurodevelopmental outcomes after preterm hypoxic-ischemic encephalopathy
Melinda Barkhuizen, Ralph van Mechelen, Marijne Vermeer, et al.
The Lancet. Neurology
|
March 22, 2017
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
David C Hess, Lawrence R Wechsler, Wayne M Clark, et al.
Stem Cells and Development
|
December 22, 2017
Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells
Raf Donders, Jeroen F J Bogie, Stylianos Ravanidis, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 12, 2010
3-Indolyl sultams as selective CRTh2 antagonists
L Nathan Tumey, Michael J Robarge, Elizabeth Gleason, et al.
Journal of Neuroinflammation
|
March 18, 2018
Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury
Supinder S Bedi, Benjamin M Aertker, George P Liao, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists
Michael J Robarge, David C Bom, L Nathan Tumey, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Scientific Reports
|
November 20, 2015
Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury
Marc A DePaul, Marc Palmer, Bradley T Lang, et al.
Journal of Neuroinflammation
|
December 25, 2015
Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain
Reint K Jellema, Daan R M G Ophelders, Alex Zwanenburg, et al.
Behavioural Brain Research
|
January 15, 2019
Systemic multipotent adult progenitor cells improve long-term neurodevelopmental outcomes after preterm hypoxic-ischemic encephalopathy
Melinda Barkhuizen, Ralph van Mechelen, Marijne Vermeer, et al.
The Lancet. Neurology
|
March 22, 2017
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
David C Hess, Lawrence R Wechsler, Wayne M Clark, et al.
Stem Cells and Development
|
December 22, 2017
Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells
Raf Donders, Jeroen F J Bogie, Stylianos Ravanidis, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 12, 2010
3-Indolyl sultams as selective CRTh2 antagonists
L Nathan Tumey, Michael J Robarge, Elizabeth Gleason, et al.
Journal of Neuroinflammation
|
March 18, 2018
Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury
Supinder S Bedi, Benjamin M Aertker, George P Liao, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists
Michael J Robarge, David C Bom, L Nathan Tumey, et al.
Page
of 3